Ps1337 ivosidenib (ag-120) induces durable remissions and transfusion independence in patients with idh1-mutant relapsed/refractory myelodysplastic syndrome in a phase 1 dose escalation and expansion study

HemaSphere(2019)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要